Carregant...
Heart Failure Primary Prevention: What Does SPRINT Add?
Hypertension is the most prevalent modifiable factor for the development of heart failure (HF). However, the optimal blood pressure (BP) target for preventing HF remains uncertain. The Systolic BP Intervention Trial (SPRINT) was a large, randomized openlabel trial (n=9361 participants) that showed t...
Guardat en:
| Publicat a: | Hypertension |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8274371/ https://ncbi.nlm.nih.gov/pubmed/33813850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.121.16503 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|